Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Pomalidomide (4 mg) is a third-generation, oral immunomodulatory antineoplastic agent (IMiD) used for relapsed/refractory multiple myeloma. It is commonly taken with dexamethasone, following failure of prior lenalidomide and proteasome inhibitor therapies.
| Strength | 4 mg |
| Packaging Size | 21 capsules |
| Uses | Multiple myeloma |
| Main Ingredients | Pomalidomide |